Prenatal sonographic findings and hematological abnormalities in fetuses with transient abnormal myelopoiesis with Down syndrome

Prenatal Diagnosis

Volumn 27, Issue 6, 2007, Pages 507-511

  Hojo, Satoshi ^a   Tsukimori, Kiyomi ^a   Kitade, Shoko ^a   Nakanami, Naoyuki ^a   Hikino, Shunji ^a   Hara, Toshiro ^a   Wake, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Fetal TAM; Hepatomegaly; Hypoalbuminemia; Liver failure; NIHF

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN SYNDROME; ECHOGRAPHY; FETUS; FETUS BLOOD; FETUS HYDROPS; HEART FAILURE; HEMATOLOGIC DISEASE; HEPATOMEGALY; HUMAN; HYPOALBUMINEMIA; LIVER FAILURE; MEDICAL RECORD; MYELOPOIESIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRANSIENT ABNORMAL MYELOPOIESIS;

BLOOD CHEMICAL ANALYSIS; DOWN SYNDROME; FEMALE; FETAL BLOOD; HEPATOMEGALY; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; LEUKOCYTE COUNT; MALE; MYELOPROLIFERATIVE DISORDERS; PREGNANCY; PROGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 34347243152     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1718     Document Type: Article

References (31)

1. Al-Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A, Pediatric Oncology Group. 2002. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 24: 2-5.
2. Arai H, Ishida A, Nakajima W, Nishinomiya F, Yamazoe A, Tkada G. 1999. Immunohistochemical study on transforming growth factor-beta1 expression in liver fibrosis of Down's syndrome with transient abnormal myelopoiesis. Hum Pathol 30: 474-476.
3. Arduini D, Rizzo G. 1990. Normal values of pulsatility index from fetal vessels: a cross sectional study on 1556 healthy fetuses. J Perinat Med 18: 165-172.
4. Baschat A, Wagner T, Malisius R, Gembruch U. 1998. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21. Prenat Diagn 18: 731-736.
5. Becroft DM. 1993. Fetal megakaryocytic dyshemopoiesis in Down syndrome: association with hepatic and pancreatic fibrosis. Pediatr Pathol 13: 811-820.
6. Bowmann JM. 1999. Hemolytic disease (erythroblastosis fetalis). In Maternal-Fetal Medicine, Creasy RK, Rensnik R (eds). Saunders: Philadelphia; 736-737.
7. DeVore GR, Siassi B, Platt LD. 1984. Fetal echocardiography. IV. M-mode assessment of ventricular size and contractility during the second and third trimesters of pregnancy in the normal fetus. Am J Obstet Gynecol 150: 981-988.
8. Dormann S, Kruger M, Hentschel R, et al. 2004. Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome. Eur J Pediatr 163: 374-377.
9. Hartung J, Chaoui R, Wauer R, Bollmann R. 1998. Fetal hepatosplenomegaly: an isolated sonographic sign of trisomy 21 in a case of myeloproliferative disorder. Ultrasound Obstet Gynecol 11: 453-455.
10. Hendricks SK, Sorensen TK, Baker ER. 1993. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder? Obstet Gynecol 82: 703-705.
11. Holzgreve W, Holzgreve B, Curry CJ. 1985. Nonimmune hydrops fetalis: diagnosis and management. Semin Perinatal 9: 52-67.
12. Homans AC, Verissimo AM, Vlacha V. 1994. Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol 16: 387-388.
13. Kanagawa T, Kanzaki T, Chiba Y. 2002. Chronologic change in the PLI value at the fetal inferior vena cava in the Japanese fetus. J Med Ultrasound 10: 94-98.
14. Kobayashi H, Horikoshi K, Yamataka A, et al. 1999. Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia. J Pediatr Surg 34: 1791-1794.
15. Lee WC, Lin HC, Hou MC, et al. 1999. Effect of anaemia on haemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 14: 370-375.
16. Macones GA, Johnson A, Tilley D, Wade R, Wapner R. 1995. Fetal hepatosplenomegaly associated with transient myeloproliferative disorder in trisomy 21. Fetal Diagn Ther 10: 131-133.
17. Mari G, Deter RL. 1992. Middle cerebral artery flow velocity waveforms in normal and small-for-gestational-age fetuses. Am J Obstet Gynecol 166: 1262-1270.
18. Massey GV, Zipursky A, Chang MN, et al., Children's Oncology Group (COG). 2006. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 107: 4606-4613.
19. Miyauchi J, Ito Y, Kawano T, Tsunematsu Y, Shimizu K. 1992. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis. Blood 80: 1521-1527.
20. Moniz CF, Nicolaides KH, Bamforth FJ, Rodeck CH. 1985. Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function in fetal and maternal plasma throughout pregnancy. J Clin Pathol 38: 468-472.
21. Ramsey M. 1996. Appendix of normal values. In High Risk Pregnancy Management Options, James D, Steer P, Weiner C, Gonik B (eds). Saunders: London; 1281-1286.
22. Robertson M, De Jong G, Mansvelt E. 2003. Prenatal diagnosis of congenital leukemia in a fetus at 25 weeks gestation with Down syndrome: case report and review of the literature. Ultrasound Obstet Gynecol 21: 486-489.
23. Schmidt W, Yarkoni S, Jeanty P, Grannum P, Hobbins JC. 1985. Sonographic measurements of the fetal spleen: clinical implications. J Ultrasound Med 4: 667-672.
24. Shimahara Y, Yamamoto N, Uyama N, et al. 2002. Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage. World J Surg 26: 451-456.
25. Smrcek JM, Baschat AA, Germer U, Gloeckner-Hofmann K, Gembruch U. 2001. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21. Ultrasound Obstet Gynecol 17: 403-409.
26. Vintzileos AM, Neckles S, Campbell WA, Andreoli JW Jr, Kaplan BM, Nochimson DJ. 1985. Fetal liver ultrasound measurements during normal pregnancy. Obstet Gynecol 66: 477-480.
27. Wallner SF, Kurnick JE, Vautrin RM, White MJ, Chapman RG, Ward HP. 1977. Levels of erythropoietin in patients with the anemias of chronic diseases and liver failure. Am J Hematol 3: 37-44.
28. Wong KY, Jones MM, Srivastava AK, Gruppo RA. 1988. Transient myeloproliferative disorder and acute non-lymphoblastic leukemia in Down syndrome. J Pediatr 112: 18-22.
29. Yagihashi N, Watanabe K, Yagihashi S. 1995. Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome. J Clin Pathol 48: 973-975.
30. Zerres K, Schwanitz G, Niesen M, Gembruch U, Hansmann M, Waldherr R. 1990. Prenatal diagnosis of acute non-lymphoblastic leukaemia in Down syndrome. Lancet 335: 117.
31. Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J. 1997. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatal 21: 97-101.